• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Herbalife Ltd.

    3/11/25 5:25:21 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    DEFA14A 1 ea0230772-04.htm ADDITIONAL MATERIALS

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    ____________________________________

    SCHEDULE 14A

    ____________________________________

    PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
    SECURITIES EXCHANGE ACT OF 1934
    (AMENDMENT NO.    )

    Filed by the Registrant

     

    ☒

     

    Filed by a Party other than the Registrant

     

    ☐

    Check the appropriate box:

    ☐

     

    Preliminary Proxy Statement

    ☐

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

     

    Definitive Proxy Statement

    ☒

     

    Definitive Additional Materials

    ☐

     

    Soliciting Material under §240.14a-12

    HERBALIFE LTD.
    (Name of Registrant as Specified In Its Charter)

    ______________________________________________________________________________

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒

     

    No fee required.

    ☐

     

    Fee paid previously with preliminary materials.

    ☐

     

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

    Your Vote Counts! HERBALIFE LTD. 2025 Annual Meeting Vote by April 22, 2025 11:59 PM ET You invested in HERBALIFE LTD. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on April 23, 2025. Get informed before you vote View the Annual Report, Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 09, 2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Meeting* April 23, 2025 8:30 AM PDT Herbalife Ltd. 800 W. Olympic Blvd. Suite 406 Los Angeles, CA *If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance. 90015

     

    Vote at www.ProxyVote.com Control # THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. HERBALIFE LTD. 2025 Annual Meeting Vote by April 22, 2025 11:59 PM ET Voting Items Board Recommends 1. Election of Directors Nominees: 1A Michael O. Johnson For 1B Richard H. Carmona For 1C Lynda Cloud For 1D Celine Del Genes For 1E Sophie L’Hélias For 1F Michael Levitt For 1G Rodica Macadrai For 1H Juan Miguel Mendoza For 1I Perkins Miller For 1J Don Mulligan For 1K Maria Otero For 2. Approve, on an advisory basis, the compensation of the Company’s named executive officers; and For 3. Ratify, on an advisory basis, the appointment of the Company’s independent registered public accounting firm for fiscal year 2025. For NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has already been given, provided your instructions are received prior to the meeting date. FLASHID-JOB# 1.00000 322,224 148,294

     

    Get the next $HLF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    5/17/2022Buy → Hold
    Argus
    5/4/2022$60.00 → $26.00Buy → Hold
    Jefferies
    More analyst ratings

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife CEO and CFO to Participate in Barclays Global Consumer Staples Conference on September 2

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced Stephan Gratziani, Chief Executive Officer, and John DeSimone, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Tuesday, September 2, 2025 at 4:30 p.m. ET (1:30 p.m. PT). A link to the live webcast will be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will also be available at the same website following the completion of the event and for six months thereafter. About Herbalife Ltd. Herbalife (NYSE:HLF) is a premier health and wellness comp

    8/19/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance

    Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806517228/en/ "Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step." - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs.

    8/6/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

    New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditure* Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the launch of MultiBurn™ — a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health*. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™ is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. This press release features multimedi

    7/7/25 8:19:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Johnson Michael covered exercise/tax liability with 125,849 shares, decreasing direct ownership by 13% to 814,726 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    9/3/25 7:00:32 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    SEC Filings

    View All

    SEC Form S-8 filed by Herbalife Ltd.

    S-8 - HERBALIFE LTD. (0001180262) (Filer)

    8/6/25 4:42:24 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    8/6/25 4:26:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    8/6/25 4:15:08 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,650 worth of shares (5,000 units at $6.73) and was granted 21,857 shares, increasing direct ownership by 20% to 161,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/6/25 8:19:33 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    B. Riley Securities reiterated coverage on Herbalife Nutrition with a new price target

    B. Riley Securities reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $17.00 from $16.00 previously

    8/1/24 8:12:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    DA Davidson initiated coverage on Herbalife Nutrition with a new price target

    DA Davidson initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.50

    9/14/23 7:19:53 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Expands Board of Directors with Appointment of Perkins Miller

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

    6/26/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance

    Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806517228/en/ "Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step." - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs.

    8/6/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Second Quarter 2025 Results on August 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its second quarter 2025 financial results after the close of trading on the NYSE on Wednesday, August 6, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/2syhpnp7 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI5

    7/1/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

    Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

    4/30/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care